Previous research has also indicated that MTF2 downregulation is linked to increased cell proliferation and metastasis in cancers like leukaemia and colorectal cancer, where its loss leads to chromatin instability and the activation of oncogenic pathways. This evidence concerns the gene MTF2 and cancer.